OncoTherapy Science, Inc. (4564.T)

JPY 26.0

(-3.7%)

Total Debt Summary of OncoTherapy Science, Inc.

  • OncoTherapy Science, Inc.'s latest annual total debt in 2023 was 106.84 Million JPY , down 0.0% from previous year.
  • OncoTherapy Science, Inc.'s latest quarterly total debt in 2024 Q1 was 92.95 Million JPY , down -13.0% from previous quarter.
  • OncoTherapy Science, Inc. reported annual total debt of - JPY in 2022, down 0.0% from previous year.
  • OncoTherapy Science, Inc. reported annual total debt of - JPY in 2021, down 0.0% from previous year.
  • OncoTherapy Science, Inc. reported quarterly total debt of - JPY for 2023 Q3, down 0.0% from previous quarter.
  • OncoTherapy Science, Inc. reported quarterly total debt of 106.84 Million JPY for 2023 FY, down 0.0% from previous quarter.

Annual Total Debt Chart of OncoTherapy Science, Inc. (2023 - 2004)

Historical Annual Total Debt of OncoTherapy Science, Inc. (2023 - 2004)

Year Total Debt Total Debt Growth
2023 106.84 Million JPY 0.0%
2022 - JPY 0.0%
2021 - JPY 0.0%
2020 - JPY 0.0%
2019 - JPY 0.0%
2018 - JPY 0.0%
2017 - JPY 0.0%
2016 - JPY 0.0%
2015 - JPY 0.0%
2014 - JPY 0.0%
2013 - JPY 0.0%
2012 - JPY 0.0%
2011 - JPY 0.0%
2010 - JPY 0.0%
2009 - JPY 0.0%
2008 - JPY -100.0%
2007 111.05 Million JPY 0.0%
2006 - JPY 0.0%
2005 - JPY 0.0%
2004 - JPY 0.0%

Peer Total Debt Comparison of OncoTherapy Science, Inc.

Name Total Debt Total Debt Difference
KOHJIN BIO CO LTD 2.46 Billion JPY 95.674%
PRISM BioLab Co.,LTD - JPY -Infinity%
GNI Group Ltd. 3.69 Billion JPY 97.112%
Linical Co., Ltd. 3 Billion JPY 96.441%
Trans Genic Inc. 2.25 Billion JPY 95.266%
MEDINET Co., Ltd. 2.3 Million JPY -4531.513%
Soiken Holdings Inc. - JPY -Infinity%
Cytori Cell Research Institute, Inc. 2.47 Billion JPY 95.677%
AnGes, Inc. 362.67 Million JPY 70.539%
Nxera Pharma Co., Ltd. 73.97 Billion JPY 99.856%
Immuno-Biological Laboratories Co., Ltd. 235.98 Million JPY 54.722%
NanoCarrier Co., Ltd. 1.1 Billion JPY 90.365%
Carna Biosciences, Inc. 182.97 Million JPY 41.603%
CanBas Co., Ltd. - JPY -Infinity%
D. Western Therapeutics Institute, Inc. 885.12 Million JPY 87.928%
RaQualia Pharma Inc. 367.71 Million JPY 70.943%
Chiome Bioscience Inc. 291 Million JPY 63.282%
Kidswell Bio Corporation 2.57 Billion JPY 95.851%
PeptiDream Inc. 22.79 Billion JPY 99.531%
Oncolys BioPharma Inc. 315.17 Million JPY 66.098%
Ribomic Inc. - JPY -Infinity%
SanBio Company Limited 665 Million JPY 83.932%
Healios K.K. 4.53 Billion JPY 97.642%
BrightPath Biotherapeutics Co., Ltd. 112.5 Million JPY 5.023%
Kubota Pharmaceutical Holdings Co., Ltd. 142.85 Million JPY 25.204%
Delta-Fly Pharma, Inc. - JPY -Infinity%
StemRIM - JPY -Infinity%
CellSource Co., Ltd. 97.54 Million JPY -9.542%
FunPep Company Limited - JPY -Infinity%
Kringle Pharma, Inc. - JPY -Infinity%
Stella Pharma Corporation 933.3 Million JPY 88.551%
TMS Co., Ltd. - JPY -Infinity%
Noile-Immune Biotech Inc. - JPY -Infinity%
Cuorips Inc. - JPY -Infinity%
K Pharma,Inc. - JPY -Infinity%
Takara Bio Inc. 968 Million JPY 88.962%
ReproCELL Incorporated - JPY -Infinity%
PhoenixBio Co., Ltd. 723.93 Million JPY 85.24%
StemCell Institute Inc. 8.78 Million JPY -1116.405%
Japan Tissue Engineering Co., Ltd. - JPY -Infinity%
CellSeed Inc. 151.25 Million JPY 29.356%